MAX Chat
Company Analysis Enzolytics Inc.
1. Summary
Advantages
- Price (0.0006 $) is less than fair price (0.000815 $)
- The stock's return over the last year (-33.33%) is higher than the sector average (-37.96%).
- Current debt level 0.2755% is below 100% and has decreased over 5 years from 12.38%.
- The company's current efficiency (ROE=61.11%) is higher than the sector average (ROE=14.7%)
Disadvantages
- Dividends (0%) are below the sector average (1.72%).
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Enzolytics Inc. | Healthcare | Index | |
|---|---|---|---|
| 7 days | 0% | -39.5% | -0.6% |
| 90 days | -14.3% | -39.8% | 7.9% |
| 1 year | -33.3% | -38% | 14.5% |
ENZC vs Sector: Enzolytics Inc. has outperformed the "Healthcare" sector by 4.63% over the past year.
ENZC vs Market: Enzolytics Inc. has significantly underperformed the market by -47.85% over the past year.
Stable price: ENZC is not significantly more volatile than the rest of the market on "OTC" over the last 3 months, with typical variations of +/- 5% per week.
Long period: ENZC with weekly volatility of -0.641% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (0.0006 $) is lower than the fair price (0.000815 $).
Price significantly below the fair price: The current price (0.0006 $) is 35.8% lower than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (-1.97) is lower than that of the sector as a whole (54.97).
P/E vs Market: The company's P/E (-1.97) is lower than that of the market as a whole (48.33).
4.3. P/BV
P/BV vs Sector: The company's P/BV (-9.77) is lower than that of the sector as a whole (5.89).
P/BV vs Market: The company's P/BV (-9.77) is lower than that of the market as a whole (4.63).
4.4. P/S
P/S vs Sector: The company's P/S indicator (659.29) is higher than that of the sector as a whole (5.01).
P/S vs Market: The company's P/S indicator (659.29) is higher than that of the market as a whole (13.27).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-16.83) is lower than that of the sector as a whole (18.25).
EV/Ebitda vs Market: The company's EV/Ebitda (-16.83) is lower than that of the market as a whole (42.28).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -17.75% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-17.75%).
Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (0.3519%).
5.4. ROE
ROE vs Sector: The company's ROE (61.11%) is higher than that of the sector as a whole (14.7%).
ROE vs Market: The company's ROE (61.11%) is higher than that of the market as a whole (51.15%).
5.5. ROA
ROA vs Sector: The company's ROA (-0.6018%) is lower than that of the sector as a whole (7.42%).
ROA vs Market: The company's ROA (-0.6018%) is lower than that of the market as a whole (35.9%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (14.2%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (10.83%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '1.72%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.5.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 1 year.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
